Back to DE D. E. Shaw & Co., Inc.

ALLOALLO
24 quarters

Position history for DED. E. Shaw & Co., Inc.'s holdings in ALLOGENE THERAPEUTICS INC

D. E. Shaw & Co., Inc. holds 4.7M shares of ALLO (ALLOGENE THERAPEUTICS INC), worth $9.8M as of 2026-Q2. The position was increased (+70.5% shares). ALLO represents 0.0% of D. E. Shaw & Co., Inc.'s portfolio.

Current Value

$9.8M

Current Shares

4.7M

Total Value Change

+$6.6M

Total Shares Change

+4.6M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
4.7M
+70.5%
$9.8M0.0%$2.08
41
2026-Q1
Increased
2.8M
+115.4%
$6.7M0.0%$2.44
44
2025-Q4
Increased
1.3M
+176.6%
$1.8M0.0%$1.37
42
2025-Q3
New
463,898
-
$575,2340.0%$1.24
34
2025-Q1
Exited
0
-100.0%
$00.0%$1.46
0
2024-Q4
Decreased
54,517
-39.6%
$116,1210.0%$2.13
0
2024-Q3
Decreased
90,325
-62.4%
$252,9100.0%$2.80
0
2024-Q2
Increased
240,255
+22.7%
$559,7940.0%$2.33
29
2024-Q1
Increased
195,778
+158.8%
$875,1270.0%$4.47
40
2023-Q4
Decreased
75,640
-39.1%
$242,8040.0%$3.21
0
2023-Q3
Decreased
124,238
-55.0%
$393,8340.0%$3.17
0
2023-Q2
Decreased
275,848
-46.2%
$1.4M0.0%$4.97
0
2023-Q1
Decreased
512,676
-22.3%
$2.5M0.0%$4.94
0
2022-Q4
Increased
660,187
+50.1%
$4.2M0.0%$6.29
37
2022-Q3
Increased
439,695
+55.0%
$4.7M0.0%$10.80
38
2022-Q2
Decreased
283,691
-71.2%
$3.2M0.0%$11.40
0
2022-Q1
Increased
985,103
+85.9%
$9M0.0%$9.11
43
2021-Q4
Increased
529,815
+2233.2%
$7.9M0.0%$14.92
44
2021-Q3
Decreased
22,708
-88.8%
$584,0000.0%$25.70
0
2021-Q2
New
202,263
-
$5.3M0.0%$26.08
37
2020-Q4
Exited
0
-100.0%
$00.0%$25.24
0
2020-Q3
New
6,459
-
$244,0000.0%$37.71
32
2020-Q1
Exited
0
-100.0%
$00.0%$19.44
0
2019-Q4
New
125,030
-
$3.2M0.0%$25.98
37

Other major holders of ALLO: TPG Group Holdings (SBS) Advisors, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used